SPAC Newbridge Inks Deal to Take AI-Health Startup Startech Public
NBRG is trading near its 52-week low of $9.59 (3.4% above the low) on light trading volume (0.3× avg).
Summary
Newbridge Acquisition, a SPAC with $57.8M in trust, has signed a definitive business combination agreement with Startech Group, an AI-driven life sciences company focused on functional water and AI-powered healthcare. Startech stockholders will receive 100 million shares of the combined entity, which will remain Nasdaq-listed under a new ticker. The deal gives the SPAC a concrete target after its going-concern warning in May, and the AI-health angle could attract growth investors. The transaction requires shareholder and regulatory approvals, with lock-ups on certain Startech shares for six months post-close. This is a material catalyst for NBRG, which has been trading near its 52-week high, as it transitions from a blank-check company to an operating business in a hot sector.
At the time of this announcement, NBRG was trading at $9.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $75.5M. The 52-week trading range was $9.59 to $10.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.